请使用支持JavaScript的浏览器! 胚胎干细胞和成体干细胞标志物_蚂蚁淘,【正品极速】生物医学科研用品轻松购|ebiomall -蚂蚁淘商城
当前位置: > 首页 > 技术文章 >
胚胎干细胞和成体干细胞标志物
来自 : 蚂蚁淘

Contents

  • EmbryonicStemCellMarkers
  • HematopoieticStemCellMarkers
  • Mesenchymal/StromalStemCellMarkers
  • NeuralStemCellMarkers
  • References

Whilestemcellsarebestdefinedfunctionally,anumberofmolecularmarkershavebeenusedtocharacterizevariousstemcellpopulations.

Althoughfunctionshaveyettobeascertainedformanyoftheseearlymarkers,theiruniqueexpressionpatternandtimingprovideausefultoolforscientiststoinitiallyidentifyaswellasisolatestemcells.Thismini-reviewsummarizesevidenceregardingtherolesofspecificmarkersindefiningembryonic,hematopoietic,mesenchymal/stromal,andneuralstemcellpopulations.Formostofthemoleculesdiscussed,studiesperformedbothinvitroandinvivosupporttheirsignificantroleincharacterizingstemcells.Untilmoreisknownaboutthenovelmarker-negativestemcellpopulation,however,uncertaintystillexistsregardingthebenefitsofusingthesemarkersaloneorinvariouscombinationswhenidentifyingandisolatingcellsforstemcellresearch.

EmbryonicStemCellMarkers

Oct-4:Oct-4(alsotermedOct-3orOct3/4),oneofthePOUtranscriptionfactors,wasoriginallyidentifiedasaDNA-bindingproteinthatactivatesgenetranscriptionviaacis-elementcontainingoctamermotif.1Itisexpressedintotipotentembryonicstemandgermcells.2,3AcriticallevelofOct-4expressionisrequiredtosustainstemcellself-renewalandpluripotency.4Differentiationofembryonicstem(ES)cellsresultsindown-regulationofOct-4,aneventessentialforaproperanddivergentdevelopmentalprogram.5Oct-4isnotonlyamasterregulatorofpluripotencythatcontrolslineagecommitment,butisalsothefirstandmostrecognizedmarkerusedfortheidentificationoftotipotentEScells.

SSEAs(StageSpecificEmbryonicAntigens):SSEAswereoriginallyidentifiedbythreemonoclonalantibodies(Abs)recognizingdefinedcarbohydrateepitopesassociatedwithlacto-andglobo-seriesglycolipids,SSEA-1,-3and-4.6SSEA-1isexpressedonthesurfaceofpreimplantation-stagemurineembryos(i.e.attheeightcellstage)andhasbeenfoundonthesurfaceofteratocarcinomastemcells,butnotontheirdifferentiatedderivatives.7,8Theoviductepithelium,endometriumandepididymis,aswellassomeareasofthebrainandkidneytubulesinadultmicehavealsobeenshowntobereactivewithSSEA-1Abs.9SSEA-3and-4aresynthesizedduringoogenesisandarepresentinthemembranesofoocytes,zygotesandearlycleavage-stageembryos.10,11BIOLOGicalrolesofthesecarbohydrate-associatedmoleculeshavebeensuggestedincontrollingcellsurfaceinteractionsduringdevelopment.6UndifferentiatedprimateEScells,humanECandEScellsexpressSSEA-3andSSEA-4,butnotSSEA-1.UndifferentiatedmouseEScellsexpressSSEA-1,butnotSSEA-3orSSEA-4.12,13

HematopoieticStemCellMarkers

CD34:ThecellsurfacesialomucinCD34
Figure1.AstructuremodelofCD133proposedbyMiragliaS.etal.30ThisproteinhasanextracellularN-terminus,5hydrophobictransmembranedomains,2smallcytoplasmicloops,2largeextracellularloopsandacytoplasmicC-termus.

hasbeenafocusofinteresteversinceitwasfoundexpressedonasmallfractionofhumanbonemarrowcells.14TheCD34+-enrichedcellpopulationfrommarrowormobilizedperipheralbloodappearsresponsIBLeformostofthehematopoieticactivity.14-21CD34hasthereforebeenconsideredtobethemostcriticalmarkerforhematopoieticstemcells(HSCs).CD34expressiononprimitivecellsisdown-regulatedastheydifferentiateintomaturecells.22ItisalsofoundonclonogenicProgenitors,however,andsomelineage-committedcells.23Althoughitsprecisefunctionisstillunknown,thepatternofexpressionofCD34suggeststhatitplaysasignificantroleinearlyhematopoiesis.22ThetheoryofCD34beingthemostprimitiveHSCmarker,however,hasrecentlybeenchallenged.Osawaetal.firstdemonstratedthatmurineHSCscouldbeCD34negative.24Inaddition,alowlevelofengraftmentandhematopoieticcapacityhasbeendemonstratedinhumanCD34-cells.25TransplantationstudiesalsoshowedrepopulatingactivityinaCD34-cellpopulationinfetalsheep.26Additionally,studieshaveshownthatbothmurineandhumanCD34+cellsmaybederivedfromCD34-cells.27,28Collectively,thesereportssuggestthepossibilitythatHSCsmaybeCD34+orCD34-andthatselectionofcellsexpressingCD34mightresultinexclusionofmoreprimitivestemcells.Nevertheless,almostallclinicalandexperimentalprotocolsincludingexvivoculture,genetherapy,andHSCtransplantationarecurrentlydesignedforcellpopulationsenrichedforCD34+cells.

Figure2.ThefamilyofABCtransportersischaracterizedbythepresenceofanATP-bindingcassetteregion,whichhydrolyzesATPtosupportenergy-dependentsubstrateexportationfromtheintracellularcytoplasmtotheextracellularspace.Full-lengthtransporterscontaintwomirrorimagehalvesthatareseparatedbyaflexiblelinkerregion(notshown).Half-transporters,e.g.ABCG2,functionashomo-orheterodimersandmaybelocalizedtotheplasmamembrane.

CD133:CD133,a120kDa,glycosylatedproteincontainingfivetransmembranedomains(Figure1),wasidentifiedinitiallybytheAC133monoclonalAb,whichrecognizesaCD34+subsetofhumanHSCs.29,30ACD133isoform,AC133-2,hasbeenrecentlyclonedandidentifiedastheoriginalsurfaceantigenrecognizedbytheAC133Ab.31CD133mayprovideanalternativetoCD34forHSCselectionandexvivoexpansion.ACD133+enrichedsubsetcanbeexpandedinasimilarmannerasaCD34+enrichedsubset,retainingitsmultilineagecapacity.32RecentstudieshaveofferedevidencethatCD133expressionisnotlimitedtoprimitivebloodcells,butdefinesuniquecellpopulationsinnon-hematopoietictissuesaswell.CD133+progenitorcellsfromperipheralbloodcanbeinducedtodifferentiateintoendothelialcellsinvitro.33Inaddition,humanneuralstemcellscanbedirectlyisolatedbyusingananti-CD133Ab.34

ABCG2:ABCG2(ATP-bindingcassettesuperfamilyGmember2)isadeterminantoftheHoechst-negativephenotypeofsidepopulation(SP)andfoundinawidevarietyofstemcells,includingHSC.35,36ABCG2isamemberofthefamilyofABCtransportersandwasfirstidentifiedinabreastcancercellline.37Itbelongstothehalf-transportergroupandisuniqueasitislocalizedtotheplasmamembrane(Figure2).38TheexpressionofABCG2appearsgreatestonCD34-cellsandisdown-regulatedwiththeacquisitionofCD34onthecellsurface.35Down-regulationinABCG2expressionisalsoobservedinvariouscommittedhematopoieticprogenitors.39ABCG2maythereforeserveasamorepromisingmarkerthanCD34forprimitiveHSCisolationandcharacterization.TheexpressionpatternofABCG2,however,isnotlimitedtoHSC.ABCG2expressionexclusivelycharacterizestheHoechstSPphenotypeincellsfromdiversesources,includingmonkeybonemarrow,mouseskeletalmuscleandEScells.35ThepotentialplasticityofSPcellshasbeendemonstratedbystudiesshowingthatcardiomyocytesandmusclecanberegeneratedfromtransplantedbonemarrow-derivedSPcells.40,41ExclusiveexpressionofABCG2onSPcellssuggeststhatABCG2maybeapotentialmarkerforpositiveselectionofpluripotentstemcellsfromvariousadultsources.ABCG2hasbeenimplicatedinplayingafunctionalroleindevelopmentalstemcellbiology(seereference42forareview).

Sca-1:Sca-1(stemcellantigen1,Ly-6A/E),an18kDaphosphatidylinositol-anchoredprotein,isamemberoftheLy-6antigenfamily.43Sca-1isthemostrecognizedHSCmarkerinmicewithbothLy-6haplotypesasitisexpressedonmultipotentHSCs.44,45Ananti-Sca-1Abisfrequentlyusedincombinationwithnegativeselectionforexpressionofanumberofcellsurfacemarkerscharacteristicofdifferentiatedcellsofhematolymphoidlineages(Lin-)toidentifyandisolatemurineHSCs.Sca-1+HSCscanbefoundintheadultbonemarrow,fetalliverandmobilizedperipheralbloodandspleenwithintheadultanimal.44-49Sca-1hasalsobeendiscoveredinseveralnon-hematopoietictissues,43however,andcanbeusedtoenrichprogenitorcellpopulationsotherthanHSCs.50Sca-1maybeinvolvedinregulatingbothBandTcellactivation.51-54

Mesenchymal/StromalStemCellMarkers

STRO-1:ThemurineIgMmonoclonalAbSTRO-1,producedfromanimmunizationwithapopulationofhumanCD34+bonemarrowcells,canidentifyacellsurfaceantigenexpressedbystromalelementsinhumanbonemarrow.55Frombonemarrowcells,thefrequencyoffibroblastcolony-formingcells(CFU-F)isenrichedapproximately100-foldintheSTRO-1+/GlycophorinA-populationthanintheSTRO-1+/GlycophorinA+population.55ASTRO-1+enrichedsubsetofmarrowcellsiscapableofdifferentiatingintomultiplemesenchymallineagesincludinghematopoiesis-supportivestromalcellswithavascularsmoothmuscle-likephenotype,ADIpocytes,osteoblastsandchondrocytes.56-59STRO-1isavaluableAbfortheidentification,isolationandfunctionalcharacterizationofhumanbonemarrowstromalcellprecursors,whicharequitedistinctfromthoseofprimitiveHSCs.

另外,还有这些marker:CD71,CD105,SH2.SH3,SH4

NeuralStemCellMarkers

Nestin:NestinisaclassVIintermediatefilamentprotein.60,61Althoughitisexpressedpredominantlyinstemcellsofthecentralnervoussystem(CNS),62itsexpressionisabsentfromnearlyallmatureCNScells.63NestinhasbeenthemostextensivelyusedmarkertoidentifyCNSstemcellswithinvariousareasofthedevelopingnervoussystemandinculturedcellsinvitro.34,64-68TheroleofnestininCNSstemcellbiology,however,remainsundefined.Althoughnestindoesnotformintermediatefilamentsbyitselfinvitroa-internexintoformhomo-andheterodimer,coiled-coilcomplexesthatmaythenformintermediatefilaments.69Itstransientexpressionhasbeensuggestedtobeamajorstepintheneuraldifferentiationpathway.61Nestinexpressionhasalsobeendiscoveredinnon-neuralstemcellpopulations,suchaspancreaticisletprogenitors70-72aswellashematopoieticprogenitors.73

PSA-NCAM(Polysialicacid-neuralcelladhesionmolecule):Theregulatedexpressionofneuralcelladhesionmolecule(NCAM)isoformsinthebrainiscriticalformanyneuraldevelopmentalprocesses.TheembryonicformofNCAM,PSA-NCAM,ishighlypolysialylatedandismainlyexpressedinthedevelopingnervoussystem.74PSA-NCAMmayberelatedtosynapticrearrangementandplasticity.75Intheadult,PSA-NCAMexpressionisrestrictedtoregionsthatretainplasticity.76Aneuronal-restrictedprecursoridentifiedbyitshighexpressionofPSA-NCAMcanundergoself-renewalanddifferentiateintomultipleneuronalphenotypes.77PSA-NCAM+neonatalbrainprecursorsarerestrictedtoaglialfateandthyroidhormonecanmodulatethemintoanoligodendrocytefate.78-80PolysialicacidmodificationsignificantlydecreasesNCAMadhesivenessandtherefore,itwasoriginallysuggestedPSA-NCAMworksasapurelyanti-adhesivefactorthatmodulatescell-cellinteractionsinpromotingbrainplasticity.IncreasingevidenceindicatesthatPSA-NCAMmayinteractwithsecretedsignalingmoleculestoperformaninstructiveroleindevelopment.81,82

Figure3.ThestructureofNGFwithamodelofthep75NeurotrophinReceptor.Theextracellulardomainofthereceptoristakenfromthetumornecrosisfactorreceptorstructureandtheintracellularportioncontainsadeathdomain.

p75NeurotrophinR(NTR):p75NTR,alsonamedlowaffinitynervegrowthfactor(NGF)receptor,isatypeItransmembraneproteinthatbelongstothetumornecrosisfactorreceptorsuperfamily(Figure3).83ItbindstoNGF,BDNF,NT-3andNT-4equally(withlowaffinity).p75NTR,whenactivatedinthepresenceofTrk,enhancesresponsestoneurotrophin(seereference84forareview).TrkCreceptorsworkingtogetherwithp75NTRhavebeensuggestedtoservecriticalfunctionsduringthedevelopmentofthenervoussystem.85Neuralcreststemcells(NCSCs)havebeenisolatedbasedontheirsurfaceexpressionofp75NTR.86,87Freshlyisolatedp75NTR+NCSCsfromperipheralnervetissuescanself-renewandgenerateneuronsandgliabothinvitroandinvivo.Inaddition,neuroepithelial-derivedp75NTR+cellsarealsoabletodifferentiateintoneurons,smoothmuscleandSchwanncellsinculture.88Recently,p75NTRhasbeenusedasamarkertoidentifymesenchymalprecursorsaswellashepaticstellatecells.89,90

References

  1. Scholer,H.R.etal.(1990)Nature344:435.
  2. Scholer,H.R.etal.(1989)EMBOJ.8:2543.
  3. Rosner,M.H.etal.(1990)Nature345:686.
  4. Niwa,H.etal.(2000)Nat.Genet.24:372.
  5. Pesce,M.etal.(2001)StemCells19:271.
  6. Bruce,A.etal.(1990)BioEssays12:173.
  7. Solter,D.etal.(1978)Proc.Natl.Acad.Sci.USA75:5565.
  8. Knowles,B.B.etal.(1980)Nature288:615.
  9. Fox,N.etal.(1981)Dev.Biol.83:391.
  10. Shevinsky,L.H.etal.(1982)Cell30:697.
  11. Kannagi,R.etal.(1983)EMBOJ.2:2355.
  12. Thomson,J.A.etal.(1998)Science282:1145.
  13. Thomson,J.A.etal.(1998)Curr.Top.Dev.Biol.38:133.
  14. Civin,C.I.etal.(1984)J.Immunol.133:157.
  15. Sutherland,H.J.etal.(1989)Blood74:1563.
  16. Bhatia,M.etal.(1997)Proc.Natl.Acad.Sci.USA94:5320.
  17. Berenson,R.J.etal.(1988)J.Clin.Invest.81:951.
  18. Civin,C.I.etal.(1996)J.Clin.Oncol.14:2224.
  19. Link,H.etal.(1996)Blood87:4903.
  20. Shpall,E.J.etal.(1997)Blood90:4313.
  21. Yabe,H.etal.(1996)BoneMarrowTransplant.17:985.
  22. Sutherland,D.R.etal.(1992)J.Hematother.1:115.
  23. Andrew,R.etal.(1989)J.Exp.Med.169:1721.
  24. Osawa,M.etal.(1996)Science273:242.
  25. Bhatis,M.etal.(1998)Nat.Med.4:1038.
  26. Zanjani,E.D.etal.(1998)Exp.Hematol.26:353.
  27. Nakamura,Y.etal.(1999)Blood94:4053.
  28. Sato,T.etal.(1999)Blood94:2548.
  29. Yin,A.H.etal.(1997)Blood90:5002.
  30. Miraglia,S.etal.(1997)Blood90:5013.
  31. Yu,Y.etal.(2002)J.Biol.Chem.277:20711.
  32. Kobari,L.etal.(2001)J.Hematother.StemCellRes.10:273.
  33. Gehling,U.M.etal.(2000)Blood95:3106.
  34. Uchida,N.etal.(2000)Proc.Natl.Acad.Sci.USA97:14720.
  35. Zhou,S.etal.(2001)Nat.Med.7:1028.
  36. Kim,M.etal.(2002)Clin.CancerRes.8:22.
  37. Doyle,L.A.etal.(1998)Proc.Natl.Acad.Sci.USA95:15665.
  38. Rocchi,E.etal.(2000)Biochem.Biophys.Res.Commun.271:42.
  39. Scharenberg,C.W.etal.(2002)Blood99:507.
  40. Jackson,K.A.etal.(2001)J.Clin.Invest.107:1395.
  41. Gussoni,E.etal.(1999)Nature401:390.
  42. Bunting,K.D.(2002)StemCells20:11.
  43. VandeRijn,M.etal.(1989)Proc.Natl.Acad.Sci.USA86:4634.
  44. Spangrude,G.I.etal.(1988)Science241:58.
  45. Spangrude,G.I.etal.(1993)Blood82:3327.
  46. Morrison,S.J.etal.(1995)Proc.Natl.Acad.Sci.USA92:10302.
  47. Kawamoto,H.etal.(1997)Int.Immunol.9:1011.
  48. Yamamoto,Y.etal.(1996)Blood88:445.
  49. Morrison,S.J.etal.(1997)Proc.Natl.Acad.Sci.USA94:1908.
  50. Welm,B.E.etal.(2002)Dev.Biol.245:42.
  51. Codias,E.K.etal.(1990)J.Immunol.144:2197.
  52. Malek,T.R.etal.(1986)J.Exp.Med.164:709.
  53. Codias,E.K.etal.(1990)J.Immunol.145:1407.
  54. Flood,P.M.etal.(1990)J.Exp.Med.172:115.
  55. Simmons,P.J.etal.(1991)Blood78:55.
  56. Gronthos,S.etal.(1994)Blood84:4164.
  57. Encina,N.R.etal.(1999)Lab.Invest.79:449.
  58. Oyajobi,B.O.etal.(1999)J.Bone.Miner.Res.14:351.
  59. Dennis,J.E.etal.(2002)CellsTissuesOrgans170:73.
  60. Hockfield,S.etal.(1985)J.Neurosci.5:3310.
  61. Lendahl,U.etal.(1990)Cell60:585.
  62. Frederiksen,K.etal.(1988)J.Neurosci.8:1144.
  63. Tohyama,T.etal.(1992)Lab.Invest.66:303.
  64. Frederiksen,K.etal.(1988)Neuron1:439.
  65. Cattaneo,C.etal.(1990)Nature347:762.
  66. Reynolds,B.A.etal.(1992)Science255:1707.
  67. Rietze,R.L.etal.(2001)Nature412:736.
  68. Carpenter,M.K.etal.(2001)Exp.Neurol.172:383.
  69. Steinert,P.M.etal.(1999)J.Biol.Chem.274:9881.
  70. Zulewski,H.etal.(2001)Diabetes50:521.
  71. Lumelsky,N.etal.(2001)Science292:1389.
  72. Lechner,A.etal.(2002)Biochem.Biophys.Res.Commun.293:670.
  73. Shih,C.C.etal.(2001)Blood98:2412.
  74. Kiss,J.Z.etal.(2001)Rev.Neurosci.12:297.
  75. Muller,D.etal.(1996)Neuron17:413.
  76. Theodosis,D.T.etal.(1994)Psychoneuroendocrinology19:455.
  77. Mayer-Proschel,M.etal.(1997)Neuron19:773.
  78. Ben-Hur,T.etal.(1998)J.Neurosci.18:5777.
  79. Theodosis,D.T.etal.(1999)J.Neurosci.19:10228.
  80. Keirstead,H.S.etal.(1999)J.Neurosci.19:7529.
  81. Muller,D.etal.(2000)Proc.Natl.Acad.Sci.USA97:4315.
  82. Kiss,J.Z.etal.(2001)BrainRes.BrainRes.Rev.36:175.
  83. Barker,P.A.etal.(1992)Mol.Cell.Biochem.110:1.
  84. Kaplan,D.R.etal.(1997)Curr.Opin.Cell.Biol.9:213.
  85. Hapner,S.J.etal.(1998)Dev.Biol.201:90.
  86. Stemple,D.L.etal.(1992)Cell71:973.
  87. Morrison,S.J.etal.(1999)Cell96:737.
  88. Mujtaba,T.etal.(1998)Dev.Biol.200:1.
  89. Campagnolo,L.etal.(2001)Biol.Reprod.64:464.
  90. Cassiman,D.etal.(2001)Hepatology33:148.
细胞相关仪器试剂耗材

免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
相关文章